70 research outputs found

    Subjective wellbeing, sense of humor and psychological health in hemodialysis patients

    Get PDF
    Objective: To investigate the relationship between satisfaction with life in general, sense of humor, and anxiety, depression and stress with subjective happiness in chronic kidney disease patients undergoing hemodialysis. Material and Methods: A cross-sectional and correlational study was developed in two units of the Diaverum dialysis clinic and one hospital unit, with 183 chronic kidney disease patients undergoing hemodialysis. An instrument was used to characterize the sociodemographic and clinical profile of the sample (age, gender, nationality, education, occupation, marital status, dialysis sessions length, presence of hypertension and diabetes): the subjective happiness scale; the satisfaction with life in general; depression, anxiety and stress scale 21; and multidimensional sense of humor scale. Inferential procedures included Spearman correlation coefficients, and multiple linear regression adjusting to age, marital status, professional activity and diabetes.Results: Subjective Happiness was positively correlated with satisfaction with life in general, and the three dimensions of Sense of Humor. Nevertheless, subjective happiness was negatively correlated with stress / anxiety and depression. Satisfaction with life in general, humor production and social use of humor, and attitude towards humor had a positive relationship with subjective happiness. However, depression had a negative relationship with subjective happiness. Conclusions: Higher levels of subjective happiness were associated with higher levels of satisfaction with life in general, and sense of humor, however they were also associated with lower levels of depression in patients undergoing hemodialysis

    Identification of the urban heat islands phenomenon in a small city: the study case of Três Rios/RJ, Brazil

    Get PDF
    The phenomenon of urban heat islands (UHI) is caused by the increase in temperatures of an urban area as a result of the development of human activities within that area, this phenomenon is usually studied in medium and large cities. This study aims to verify if the phenomenon of UHI occurs in the municipality of Três Rios – RJ, a small sized city. This study included the use of mobile transect, through pre-established data collection points/stations. Five data collection points were selected, from which one was included in a rural area, one in the Parque Natural Municipal (Urban Park, within the city), and three points within the urbanized area. The equipment used was the Brunton® / ADC PRO handheld weather station. The data collection period ranged from September 2018 until July 2019, which included the four seasons. Measurements were taken at 6:00, 12:00, 15:00, 18:00, and 21:00h, in alternate days during the study period. Considering the temperature measurements, two different indicators of thermal variability were used. Strong magnitude heat islands were detected, taking into consideration the relevant variation of maximum temperatures observed in the urban area when compared to the rural area. The results indicate the most affected populations to be the ones located within urban areas, mostly individuals under socioeconomic vulnerability. The results obtained can be used as support for the development of strategies to minimize the thermal discomfort to populations exposed to the influence of higher magnitude urban heat islands.O fenômeno Ilha de Calor Urbana (ICU) consiste no aumento de temperaturas de uma área urbana influenciado pelo desenvolvimento de atividades antrópicas e comumente estudado em cidades de médio e grande porte. O objetivo do presente estudo foi verificar se há ocorrência do fenômeno ICU na cidade de Três Rios - RJ, uma cidade de pequeno porte. Esse trabalho consistiu no uso de um transecto móvel, a partir de pontos/estações preestabelecidos. Foram selecionados cinco pontos de medidas, sendo um ponto na zona rural, um ponto no Parque Natural Municipal da cidade (parque urbano) e três pontos na área urbana. O equipamento portátil utilizado foi uma Central Meteorológica Brunton® / ADC PRO. O período analisado compreendeu de setembro/2018 a julho/2019, englobando as quatro estações do ano. As medidas foram realizadas as 6:00, 12:00, 15:00, 18:00 e 21:00 horas em dias alternados dos meses em questão. A partir das medições de temperatura dois indicadores distintos de diferenciação térmica foram considerados, sendo possível constatar ilhas de calor de forte magnitude, considerando relevante variação das máximas das temperaturas identificadas para zona urbana em relação a zona rural. De acordo com a análise dos resultados a população mais afetada seria a que reside na área urbanizada, sobretudo a população em vulnerabilidade socioeconômica. Os resultados obtidos poderão servir como subsídio para a elaboração de estratégias, que visam minimizar o desconforto térmico na população em áreas onde ocorreram maiores amplitudes sob influência das ilhas de calor

    A Novel Heat Transfer Coefficient Identification Methodology for the Profile Extrusion Calibration Stage

    Get PDF
    International audienceA new method to compute heat transfer coefficients of the profile extrusion process calibration stage, in conjunction with a prototype calibration system [1], is proposed. The methodology involves two major ingredients: a numerical modeling code and a fitting procedure. The code, based on the Finite Volume Method, computes the steady-state solution for the heat transfer problem. The software carefully handles discontinuous solutions as well as discontinuities of the velocity and the material characteristics. Fitting procedure introduces alternative algorithms we have tested and assessed in [2]. A real case study demonstrates the advantages of using the new proposed methodology when compared with the previously applied [1]

    Biossorção do corante índigo carmim por Pennisetum purpureum Schumach. 1827 (Poales: Poaceae) (Capim elefante)

    Get PDF
    As indústrias têxteis devem tratar seus efluentes antes do descarte em corpos hídricos. Esse tratamento objetiva majoritariamente a remoção de corantes, cuja interação com o meio ambiente pode causar grandes danos a natureza. A Biossorção tem se mostrado muitas vezes uma técnica econômica e eficaz na remoção de boa parte destes corantes. Deste modo propomos aplicar como biossorvente, o Pennisetum purpureum Schumach., 1827 (Poales: Poaceae) (Capim elefante), para tratar   efluentes contendo o corante Índigo Carmim. Os ensaios de remoção do corante foram realizados em batelada nas seguintes condições: variando as temperaturas (30, 40, 60 e 100 ± 2 ºC); agitação constante de 150 rpm; pH 5,5; 0,5 g de biossorvente; e em diferentes concentrações de corante, de 25 a 65 mg·L-1. O mecanismo de biossorção foi bem descrito pelo modelo de Langmuir. A capacidade biossortiva máxima foi de 17,51 mg?g-1.  A investigação termodinâmica indicou que a biossorção é um processo favorável e espontâneo em temperaturas até 60 ºC, acima disso o sistema apresentou uma redução da capacidade biossortiva. Deste modo, a utilização de Pennisetum purpureum Schumach., 1827 (Poales: Poaceae) como biossorvente para a remoção do corante índigo carmim de efluentes têxteis se mostrou uma   nova alternativa eficaz e econômic

    Práticas artísticas no ensino básico e secundário

    Get PDF
    A matéria-prima de que trata esta revista é base de trabalho para um ensino artístico alargado, estendendo-se fora dos limites da aula, transgredindo os limites formais dos curricula, implicando património e riqueza cultural, sensibilizando para o imaterial, criando públicos apreciadores e também agentes criadores. É toda uma comunidade que se interliga através dos valores imateriais que sempre foram os da arte. A tarefa do educador é muito alargada: exige-se que esteja à altura deste desígnio humanista, que é também um desafio ao destino da humanidade: pela educação artística constroem-se futuros, e sem arte há intolerância, materialismo, indiferença, alienação, morte. Os tempos que se vivem são exigentes. As questões da pós modernidade estão muito acesas, desde as que nos obrigam ao desassossego, como a sustentabilidade e a poluição, como as que nos implicam politicamente, como a justiça, os direitos civis, a desigualdade. Tudo isto é matéria com a qual se amassa um barro que pode ser mais ou menos criativo: trata-se de extrair a matéria-prima com que se pode fazer os blocos que constroem o futuro. Aos profissionais da educação e do ensino, esta consciência, ao mesmo tempo desamparada – os cortes da economia neoliberal transformaram a arte em indústria, e a sua educação em criação de consumidores – e ao mesmo tempo vigilante e interventiva. Os artigos que responderam a esta chamada, respondem, cada um a seu modo, a este desassossego, a este desconforto, a este mal-estar contemporâneo. Dispuseram-se segundo uma sequência que se articula com base em temas afins que se podem descrever sucintamente: Todos os que participaram neste número mostraram a sua matéria-prima, a sua reação à falta que a arte nos faz. A chamada soa, e ressoa, e é necessário que seja por todos ouvida, em todos os países. É simples: as artes estão em perigo. Perigo porque há menos horas, menos professores, menos opções, menos conhecimento. As reduções no horário, a eliminação de disciplinas tão importantes como a história da arte, fazem de cada professor um agente da resistência, um ser mais implicado na sobrevivência da chama da criação. Matéria-prima: matéria para resgatar a verdade humana, a arte, a expressão mais valiosa da sua vaidade. Resgatar o homem que Michel Foucault (1988: 412) vê ameaçado, como um rosto na areia, desenhado à beira-mar.info:eu-repo/semantics/publishedVersio

    Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

    Get PDF
    Background: Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without causing significant sodium retention. We report the long-term effects of treatment with atrasentan on major renal outcomes. Methods: We did this double-blind, randomised, placebo-controlled trial at 689 sites in 41 countries. We enrolled adults aged 18–85 years with type 2 diabetes, estimated glomerular filtration rate (eGFR)25–75 mL/min per 1·73 m 2 of body surface area, and a urine albumin-to-creatinine ratio (UACR)of 300–5000 mg/g who had received maximum labelled or tolerated renin–angiotensin system inhibition for at least 4 weeks. Participants were given atrasentan 0·75 mg orally daily during an enrichment period before random group assignment. Those with a UACR decrease of at least 30% with no substantial fluid retention during the enrichment period (responders)were included in the double-blind treatment period. Responders were randomly assigned to receive either atrasentan 0·75 mg orally daily or placebo. All patients and investigators were masked to treatment assignment. The primary endpoint was a composite of doubling of serum creatinine (sustained for ≥30 days)or end-stage kidney disease (eGFR <15 mL/min per 1·73 m 2 sustained for ≥90 days, chronic dialysis for ≥90 days, kidney transplantation, or death from kidney failure)in the intention-to-treat population of all responders. Safety was assessed in all patients who received at least one dose of their assigned study treatment. The study is registered with ClinicalTrials.gov, number NCT01858532. Findings: Between May 17, 2013, and July 13, 2017, 11 087 patients were screened; 5117 entered the enrichment period, and 4711 completed the enrichment period. Of these, 2648 patients were responders and were randomly assigned to the atrasentan group (n=1325)or placebo group (n=1323). Median follow-up was 2·2 years (IQR 1·4–2·9). 79 (6·0%)of 1325 patients in the atrasentan group and 105 (7·9%)of 1323 in the placebo group had a primary composite renal endpoint event (hazard ratio [HR]0·65 [95% CI 0·49–0·88]; p=0·0047). Fluid retention and anaemia adverse events, which have been previously attributed to endothelin receptor antagonists, were more frequent in the atrasentan group than in the placebo group. Hospital admission for heart failure occurred in 47 (3·5%)of 1325 patients in the atrasentan group and 34 (2·6%)of 1323 patients in the placebo group (HR 1·33 [95% CI 0·85–2·07]; p=0·208). 58 (4·4%)patients in the atrasentan group and 52 (3·9%)in the placebo group died (HR 1·09 [95% CI 0·75–1·59]; p=0·65). Interpretation: Atrasentan reduced the risk of renal events in patients with diabetes and chronic kidney disease who were selected to optimise efficacy and safety. These data support a potential role for selective endothelin receptor antagonists in protecting renal function in patients with type 2 diabetes at high risk of developing end-stage kidney disease. Funding: AbbVie

    Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Get PDF
    Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

    Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

    Get PDF
    BACKGROUND: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. METHODS: This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. FINDINGS: Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. INTERPRETATION: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. FUNDING: UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca
    corecore